论文部分内容阅读
目的探讨金水宝胶囊联合贝那普利治疗糖尿病肾病的疗效。方法将2009年2月—2011年12月期间该科收治的54例糖尿病肾病患者随机分为两组:观察组27例,接受降糖、贝那普利、金水宝治疗;对照组27例,仅接受降糖、贝那普利治疗。所有患者均接受2个月的治疗,现比较两组患者的疗效。结果①观察组治疗前后24h尿蛋白定量的降低幅度显著大于对照组(P<0.01)。②观察组的治疗有效率显著高于对照组(P<0.05)。结论金水宝胶囊联合贝那普利治疗糖尿病肾病的疗效确切,可降低患者的尿蛋白丢失量。
Objective To investigate the curative effect of Jinshuibao capsule combined with benazepril on diabetic nephropathy. Methods 54 patients with diabetic nephropathy admitted in this department from February 2009 to December 2011 were randomly divided into two groups: observation group (n = 27) received hypoglycemic treatment, benazepril treatment and jinshui Bao treatment group (n = 27) Only hypoglycemic, benazepril treatment. All patients received 2 months of treatment, the efficacy of the two groups are compared. Results ① The decrease of urinary protein in observation group before and after treatment was significantly greater than that in control group (P <0.01). ② The observation group’s treatment efficiency was significantly higher than that of the control group (P <0.05). Conclusion Jinshuibao capsule combined with benazepril treatment of diabetic nephropathy curative effect is exact, can reduce the patient’s urine protein loss.